GQG Partners
EW icon

GQG Partners’s Edwards Lifesciences EW Stock Holding History

GQG Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,518
Closed -$361K – 70
2020
Q3 		$361K Hold
4,518
– – ﹤0.01% 63
2020
Q2 		$312K Hold
4,518
– – ﹤0.01% 59
2020
Q1 		$284K Hold
4,518
– – ﹤0.01% 52
2019
Q4 		$351K Buy
+4,518
New +$353K ﹤0.01% 52

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

GQG Partners's EW Position: Q4 2020 in Review

GQG Partners sold out of Edwards Lifesciences (EW) in Q4 2020, closing a stake of 4,518 shares — an estimated $361K sold.

GQG Partners first reported a position in EW in Q4 2019 and held it in 4 quarters. The position peaked at $361K in Q3 2020. 1,160 funds tracked by Wall St. Rank hold EW as of Q4 2020.

  • GQG Partners reported no remaining Edwards Lifesciences position as of Q4 2020 after selling out during the quarter.
  • GQG Partners sold 4,518 Edwards Lifesciences shares in Q4 2020, an estimated $361K.
  • GQG Partners first reported a position in Edwards Lifesciences in Q4 2019 and held it in 4 quarters.
  • GQG Partners's Edwards Lifesciences position peaked at $361K in Q3 2020.
  • 1,160 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2020.

Based on GQG Partners's 13F filing for Q4 2020, filed 12 Feb 2021.